肝豆状核变性的基因诊断研究进展
收稿日期: 2021-07-02
网络出版日期: 2022-07-25
基金资助
国家自然科学青年科学基金项目(82002126);广慈卓越青年培养计划(GCQN-2017-B20)
姚碧莲, 张欣欣, 韩悦 . 肝豆状核变性的基因诊断研究进展[J]. 内科理论与实践, 2021 , 16(05) : 354 -358 . DOI: 10.16138/j.1673-6087.2021.05.013
| [1] | Bull PC, Thomas GR, Rommens JM, et al. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene[J]. Nat Genet, 1993, 5(4): 327-337. |
| [2] | Tanzi RE, Petrukhin K, Chernov I, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene[J]. Nat Genet, 1993, 5(4): 344-350. |
| [3] | Merle U, Schaefer M, Ferenci P, et al. Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study[J]. Gut, 2007, 56(1): 115-120. |
| [4] | Pellecchia MT, Criscuolo C, Longo K, et al. Clinical presentation and treatment of Wilson’s disease: a single-centre experience[J]. Eur Neurol, 2003, 50(1): 48-52. |
| [5] | Hedera P. Update on the clinical management of Wilson’s disease[J]. Appl Clin Genet, 2017, 10: 9-19. |
| [6] | Hedera P. Wilson’s disease: a master of disguise[J]. Parkinsonism Relat Disord, 2019, 59: 140-145. |
| [7] | Ala A, Walker AP, Ashkan K, et al. Wilson’s disease[J]. Lancet, 2007, 369(9559): 397-408. |
| [8] | Coffey AJ, Durkie M, Hague S, et al. A genetic study of Wilson’s disease in the United Kingdom[J]. Brain, 2013, 136 Pt 5: 1476-1487. |
| [9] | Hu WB, Han YZ, Xue BC, et al. Epidemiological investigation of Wilson disease in Hanshan county, Anhui Province[J]. Chin Med J, 2010, 91: 894-897. |
| [10] | 胡文彬, 韩咏竹, 杨任民, 等. 安徽省金寨县和利辛县汉族人群肝豆状核变性的患病率调查[J]. 安徽医学, 2011, 33(6):734-737. |
| [11] | Xie JJ, Wu ZY. Wilson’s disease in China[J]. Neurosci Bull, 2017, 33(3): 323-330. |
| [12] | 中华医学会神经病学分会帕金森病及运动障碍学组, 中华医学会神经病学分会神经遗传病学组. 肝豆状核变性的诊断与治疗指南[J]. 中华神经科杂志, 2008, 41(8): 566-569. |
| [13] | 杨任民,主编. 肝豆状核变性[M]. 北京: 人民卫生出版社, 2015: 219-222. |
| [14] | 中华医学会神经病学分会神经遗传病学组. 中国肝豆状核变性诊治指南2021[J]. 中华神经科杂志, 2021, 54(4): 310-319. |
| [15] | European Association for Study of Liver. EASL clinical practice guidelines: Wilson’s disease[J]. J Hepatol, 2012, 56(3): 671-685. |
| [16] | QIAGEN Digital Insights. Announcing HGMD professional 2018.2![EB/OL]. 2018. https://digitalinsights.qiagen.com/news/blog/clinical/announcing-2018-2-release-hgmd-professional/. |
| [17] | Chen C, Shen B, Xiao JJ, et al. Currently clinical views on genetics of Wilson’s disease[J]. Chin Med J (Engl), 2015, 128(13): 1826-1830. |
| [18] | Usta J, Wehbeh A, Rida K, et al. Phenotype-genotype correlation in Wilson disease in a large Lebanese family: association of c.2299insC with hepatic and of p. Ala1003Thr with neurologic phenotype[J]. PLoS One, 2014, 9(11): e109727. |
| [19] | Dong Y, Wang RM, Yang GM, et al. Role for biochemi-cal assays and kayser-fleischer rings in diagnosis of Wilson’s disease[J]. Clin Gastroenterol Hepatol, 2021, 19(3): 590-596. |
| [20] | Wu ZY, Wang N, Lin MT, et al. Mutation analysis and the correlation between genotype and phenotype of Arg778Leu mutation in chinese patients with Wilson disease[J]. Arch Neurol, 2001, 58(6): 971-976. |
| [21] | Cheng N, Wang H, Wu W, et al. Spectrum of ATP7B mutations and genotype-phenotype correlation in large-scale Chinese patients with Wilson disease[J]. Clin Genet, 2017, 92(1): 69-79. |
| [22] | Li X, Lu Z, Lin Y, et al. Clinical features and mutational analysis in 114 young children with Wilson disease from South China[J]. Am J Med Genet A, 2019, 179(8): 1451-1458. |
| [23] | 杨任民, 范玉新. 肝豆状核变性基因的一种新型错义突变[J]. 中华医学杂志, 1997, 77(5): 344-347. |
| [24] | Li X H, Lu Y, Ling Y, et al. Clinical and molecular characterization of Wilson’s disease in China: identification of 14 novel mutations[J]. BMC Med Genet, 2011, 12: 6. |
| [25] | Dong Y, Ni W, Chen W J, et al. Spectrum and classification of ATP7B variants in a large cohort of Chinese patients with Wilson’s disease guides genetic diagnosis[J]. Theranostics, 2016, 6(5): 638-649. |
| [26] | Chen HL, Li HY, Wu JF, et al. Panel-based next-generation sequencing for the diagnosis of cholestatic genetic liver diseases[J]. J Pediatr, 2019, 205: 153-159. |
| [27] | 吴志英, 王柠, 林珉婷, 等. Wilson病基因突变类型与临床表型的关系[J]. 中华医学杂志, 2003, 83(4): 309-311. |
| [28] | Liu XQ, Zhang YF, Liu TT, et al. Correlation of ATP7B genotype with phenotype in Chinese patients with Wilson disease[J]. World J Gastroenterol, 2004, 10(4): 590-593. |
| [29] | Zhu M, Dong Y, Ni W, et al. Defective roles of ATP7B missense mutations in cellular copper tolerance and copper excretion[J]. Mol Cell Neurosci, 2015, 67: 31-36. |
| [30] | Zhu M, Ni W, Dong Y, et al. EGFP tags affect cellular localization of ATP7B mutants[J]. CNS Neurosci Ther, 2013, 19(5): 346-351. |
| [31] | Huang F, Liang XL, Wang Y, et al. Study on correlation between gene Arg778Leu mutation and clinical manifestation in Wilson’s disease[J]. Chin J Neurol, 2000, 33: 290-291. |
| [32] | Hua R, Hua F, Jiao Y, et al. Mutational analysis of ATP7B in Chinese Wilson disease patients[J]. Am J Transl Res, 2016, 8(6): 2851-2861. |
| [33] | Cocoçs R, Çsendroiu A, Schipor S, et al. Genotype-phenotype correlations in a mountain population community with high prevalence of Wilson’s disease: genetic and clinical homogeneity[J]. PLoS One, 2014, 9(6): e98520. |
| [34] | Braiterman LT, Murthy A, Jayakanthan S, et al. Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B [J]. Proc Natl Acad Sci U S A, 2014, 111(14): E1364-E1373. |
| [35] | Incollu S, Lepori MB, Zappu A, et al. DNA and RNA studies for molecular characterization of a gross deletion detected in homozygosity in the NH2-terminal region of the ATP7B gene in a Wilson disease patient[J]. Mol Cell Probes, 2011, 25(5-6): 195-198. |
| [36] | Møller LB, Horn N, Jeppesen TD, et al. Clinical pre-sentation and mutations in Danish patients with Wilson disease[J]. Eur J Hum Genet, 2011, 19(9): 935-941. |
| [37] | McCann CJ, Jayakanthan S, Siotto M, et al. Single nucleotide polymorphisms in the human ATP7B gene modify the properties of the ATP7B protein[J]. Metallomics, 2019, 11(6): 1128-1139. |
| [38] | van De Sluis B, Rothuizen J, Pearson PL, et al. Identification of a new copper metabolism gene by positional cloning in a purebred dog population[J]. Hum Mol Genet, 2002, 11(2): 165-173. |
| [39] | Stuehler B, Reichert J, Stremmel W, et al. Analysis of the human homologue of the canine copper toxicosis gene MURR1 in Wilson disease patients[J]. J Mol Med (Berl), 2004, 82(9): 629-634. |
| [40] | Gromadzka G, Kruszyńska M, Wierzbicka D, et al. Gene variants encoding proteins involved in antioxidant defense system and the clinical expression of Wilson disease[J]. Liver Int, 2015, 35(1): 215-222. |
| [41] | Roy S, Pal P, Ghosh S, et al. Potential role of brain-derived neurotrophic factor and dopamine receptor D2 gene variants as modifiers for the susceptibility and clinical course of Wilson’s disease[J]. Neuromolecular Med, 2018, 20(3): 401-408. |
| [42] | Gu YH, Kodama H, Du SL. Apolipoprotein E genotype analysis in Chinese Han ethnic children with Wilson’s disease, with a concentration on those homozygous for R778L[J]. Brain Dev, 2005, 27(8): 551-553. |
| [43] | Kocabay G, Tutuncu Y, Yilmaz H, et al. Impact of apolipoprotein E genotypes on phenotypic expression in Turkish patients with Wilson’s disease[J]. Scand J Gastroenterol, 2009, 44(10): 1270-1271. |
| [44] | Roy S, Ganguly K, Pal P, et al. Influence of Apolipoprotein E polymorphism on susceptibility of Wilson disease[J]. Ann Hum Genet, 2018, 82(2): 53-59. |
| [45] | Kluska A, Kulecka M, Litwin T, et al. Whole-exome sequencing identifies novel pathogenic variants across the ATP7B gene and some modifiers of Wilson’s disease phenotype[J]. Liver Int, 2019, 39(1): 177-186. |
| [46] | Simon I, Schaefer M, Reichert J, et al. Analysis of the human Atox 1 homologue in Wilson patients[J]. World J Gastroenterol, 2008, 14(15): 2383-2387. |
| [47] | Weiss KH, Runz H, Noe B, et al. Genetic analysis of BIRC4/XIAP as a putative modifier gene of Wilson disease[J]. J Inherit Metab Dis, 2010, 33 Suppl 3: S233-S240. |
| [48] | Stättermayer AF, Traussnigg S, Dienes HP, et al. Hepatic steatosis in Wilson disease: role of copper and PNPLA3 mutations[J]. J Hepatol, 2015, 63(1): 156-163. |
| [49] | Gromadzka G, Rudnicka M, Chabik G, et al. Genetic variability in the methylenetetrahydrofolate reductase gene (MTHFR) affects clinical expression of Wilson’s disease[J]. J Hepatol, 2011, 55(4): 913-919. |
| [50] | Mordaunt CE, Kieffer DA, Shibata NM, et al. Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers[J]. Epigenetics Chromatin, 2019, 12(1): 10. |
/
| 〈 |
|
〉 |
